doi: 10.1016/S0140-6736(97)08360-8.
Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
Affiliations
- PMID: 9439509
- DOI: 10.1016/S0140-6736(97)08360-8
Item in Clipboard
Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
Lancet.
.
Abstract
Neuronal intranuclear inclusions have been found in the brain of a transgenic mouse model of Huntington's disease and in necropsy brain tissue of patients with Huntington's disease. We suggest that neuronal intranuclear inclusions are the common neuropathology for all inherited diseases caused by expansion of polyglutamine repeats. We also suggest that patients with a pathological diagnosis of neuronal intranuclear hyaline inclusion disease may also have polyglutamine repeat expansions.
Similar articles
-
Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.Neuroreport. 1998 Jun 1;9(8):1823-6. doi: 10.1097/00001756-199806010-00028. Neuroreport. 1998. PMID: 9665608
-
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434303 Free PMC article.
-
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.Neurobiol Dis. 1998 Apr;4(6):387-97. doi: 10.1006/nbdi.1998.0168. Neurobiol Dis. 1998. PMID: 9666478
-
Transgenic models of Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.
-
Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1013-9. doi: 10.1098/rstb.1999.0453. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434300 Free PMC article. Review.
Cited by
-
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.J Neurosci. 2006 Feb 1;26(5):1635-45. doi: 10.1523/JNEUROSCI.3706-05.2006. J Neurosci. 2006. PMID: 16452687 Free PMC article.
-
Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.Neurotox Res. 2001 Jul;3(3):259-75. doi: 10.1007/BF03033265. Neurotox Res. 2001. PMID: 15111251
-
Transgenic mice in the study of polyglutamine repeat expansion diseases.Brain Pathol. 1998 Oct;8(4):699-714. doi: 10.1111/j.1750-3639.1998.tb00196.x. Brain Pathol. 1998. PMID: 9804379 Free PMC article. Review.
-
Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.Int J Mol Sci. 2024 Mar 29;25(7):3845. doi: 10.3390/ijms25073845. Int J Mol Sci. 2024. PMID: 38612657 Free PMC article. Review.
-
Transcriptional signatures in Huntington's disease.Prog Neurobiol. 2007 Nov;83(4):228-48. doi: 10.1016/j.pneurobio.2007.03.004. Epub 2007 Apr 1. Prog Neurobiol. 2007. PMID: 17467140 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
